Overview
About Countagen
Countagen is a Stockholm-based biotechnology company providing the new gold standard for high-resolution genome editing Quality Control (QC).
We developed LockSeq—a novel targeted multiplex NGS library preparation platform—to solve the "Validation Wall" inherent in traditional PCR-based library preps. By utilizing a unique gap-fill ligation-lock chemistry, we fundamentally eliminate target dropout and amplification bias, providing researchers with the confidence required for preclinical and IND-enabling studies.
The LockSeq Advantage:
- Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction.
- High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency.
- Broad Compatibility: Platform-neutral performance across Illumina and Oxford Nanopore systems.
- Cost-Efficient Scalability: Scale panels and samples with zero target dropout.
📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.
🌐 Visit us at: www.countagen.com
We developed LockSeq—a novel targeted multiplex NGS library preparation platform—to solve the "Validation Wall" inherent in traditional PCR-based library preps. By utilizing a unique gap-fill ligation-lock chemistry, we fundamentally eliminate target dropout and amplification bias, providing researchers with the confidence required for preclinical and IND-enabling studies.
The LockSeq Advantage:
- Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction.
- High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency.
- Broad Compatibility: Platform-neutral performance across Illumina and Oxford Nanopore systems.
- Cost-Efficient Scalability: Scale panels and samples with zero target dropout.
📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.
🌐 Visit us at: www.countagen.com